Skip to main navigation Skip to search Skip to main content

Structural insights and therapeutic targets in Acinetobacter baumannii capsule biosynthesis

  • Woo Cheol Lee
  • , Junho Jeong
  • , Chae Yeong Lee
  • , Hyunjoon Cho
  • , Man Hwan Oh
  • , Je Chul Lee
  • , Jee Young Lee
  • , Yangmee Kim
  • Konkuk University
  • Dankook University
  • Kyungpook National University
  • Daegu-Gyeongbuk Medical Innovation Foundation

Research output: Contribution to journal › Article › peer-review

Abstract

Gram-negative bacteria produce nonulosonic acids, a family of nine-carbon sugars that mimic host sialic acids and may contribute to bacterial virulence. The nonulosonic acid C8-epimeric 5,7-di-N-acetyllegionaminic acid (8-epi-Leg5,7Ac2) is a component of the K-locus 49 (KL49) capsule of hypervirulent Acinetobacter baumannii, and its epimerization is proposed to be mediated by ElaA, ElaB, and ElaC. We identified a KL49 strain that induces lethal sepsis in mice and found deletion of elaA, elaB, or elaC abolished lethality and markedly reduced capsule production. Crystal structures of ElaB, ElaA, and ElaC revealed conserved N-acetyl recognition underlying CMP-Leg5,7Ac2 synthesis and regioselective C8 epimerization. Together, these genetic, structural, and in vivo findings identify ElaABC as potential antivirulence targets in emerging hypervirulent KL49 A. baumannii strains.

Original languageEnglish
Pages (from-to)2947-2960
Number of pages14
JournalFEBS Letters
Volume600
Issue number19
DOIs
StatePublished - Oct 2026

Keywords

  • 8-epi-legionaminic acid
  • Acinetobacter baumannii
  • ElaA
  • ElaB
  • ElaC
  • KL49
  • Vibrio vulnificus
  • capsular polysaccharide
  • nonulosonic acid

Fingerprint

Dive into the research topics of 'Structural insights and therapeutic targets in Acinetobacter baumannii capsule biosynthesis'. Together they form a unique fingerprint.

Cite this